Evidence-Based Medicine Guidelines
Ribavirin plus interferon versus interferon for chronic hepatitis C
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ribavirin Plus Interferon Versus Interferon for Chronic Hepatitis C." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456724/all/Ribavirin_plus_interferon_versus_interferon_for_chronic_hepatitis_C.
Ribavirin plus interferon versus interferon for chronic hepatitis C. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456724/all/Ribavirin_plus_interferon_versus_interferon_for_chronic_hepatitis_C. Accessed May 29, 2023.
Ribavirin plus interferon versus interferon for chronic hepatitis C. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456724/all/Ribavirin_plus_interferon_versus_interferon_for_chronic_hepatitis_C
Ribavirin Plus Interferon Versus Interferon for Chronic Hepatitis C [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 May 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456724/all/Ribavirin_plus_interferon_versus_interferon_for_chronic_hepatitis_C.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ribavirin plus interferon versus interferon for chronic hepatitis C
ID - 456724
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456724/all/Ribavirin_plus_interferon_versus_interferon_for_chronic_hepatitis_C
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
